Effect of neonatal administration of a retroviral vector expressing α-l-iduronidase upon lysosomal storage in brain and other organs in mucopolysaccharidosis I mice

Sarah Chung, Xiucui Ma, Yuli Liu, David Lee, Mindy Tittiger, Katherine P. Ponder

Research output: Contribution to journalArticle

38 Scopus citations

Abstract

Mucopolysaccharidosis I (MPS I) due to deficient α-l-iduronidase (IDUA) activity results in accumulation of glycosaminoglycans in many cells. Gene therapy could program cells to secrete IDUA modified with mannose 6-phosphate (M6P), and enzyme could be taken up by other cells via the M6P receptor. We previously reported that newborn MPS I mice that were injected intravenously with 109 (high-dose) or 108 (low-dose) transducing units/kg of a retroviral vector (RV) expressing canine IDUA achieved stable levels of IDUA activity in serum and had reduced disease in heart, eye, ear, and bone in a dose-dependent fashion. However, the dose required for improvement in manifestations of disease in other organs was not reported. High-dose and low-dose RV mice with an average serum IDUA activity of 1037 ± 90 U/ml (471-fold normal) and 43 ± 12 U/ml (20-fold normal), respectively, had complete correction of biochemical and pathological evidence of disease in the liver, spleen, kidney, and small intestines. Although mice that received high-dose RV had complete correction of lysosomal storage in thymus, ovary, lung, and testis, correction in these organs was only partial for those that received low-dose RV. Storage in brain was almost completely corrected with high-dose RV, but was not improved with low-dose RV. The correction of disease in brain may be due to diffusion of enzyme from blood. We conclude that high-dose RV prevents biochemical and pathological manifestations of disease in all organs in MPS I mice including brain.

Original languageEnglish
Pages (from-to)181-192
Number of pages12
JournalMolecular genetics and metabolism
Volume90
Issue number2
DOIs
StatePublished - Feb 1 2007

Keywords

  • Gene therapy
  • Glycosaminoglycan
  • Iduronidase
  • Liver
  • Lysosomal storage disease
  • Mucopolysaccharidosis
  • Neonatal
  • Retroviral vector

Fingerprint Dive into the research topics of 'Effect of neonatal administration of a retroviral vector expressing α-l-iduronidase upon lysosomal storage in brain and other organs in mucopolysaccharidosis I mice'. Together they form a unique fingerprint.

  • Cite this